Theraclion SA announced a private placement of common shares for the gross proceeds of €7 million on May 25, 2023. The transaction will include participation from returning investor Furui Medical Science Company Luxembourg S.à r.l for 31.28% stake. The company has raised investor's stake from 7.15% to 31.28%.

The transaction has been approved by the 8th supervisory board during its 2nd meeting of the company.